CC BY-NC-ND 4.0 · International Journal of Epilepsy 2022; 08(02): 043
DOI: 10.1055/s-0044-1787803
Editorial

Editor's Message

Man Mohan Mehndiratta
1   Principal Director, Department of Neurology, Centre for Neurosciences, B.L. Kapur Hospital (Max Health Care Group), New Delhi, India
,
R. Lakshmi Narasimhan
2   Professor and HOD, Department of Neurology, Sri Ramachandra Medical College, Sriher, Chennai, Tamil Nadu, India
,
Arushi G. Saini
3   Division of Pediatric Neurology, Department of Pediatrics, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations
 

    It is our great pleasure to revive and present to you Volume 8, Issue 2 of the International Journal of Epilepsy (IJEP). Due to some glitches, the release of the current issue, originally due in the second half of 2022, was delayed. But with our renewed team and revitalized enthusiasm, we intend to scale the gap swiftly and bring to you the excellent scientific work of our contributors from across the globe.

    In this issue, the neuropharmacological review by Dr Jefry Stephan et al discusses the antisense molecules targeted for epilepsy and their progress in epilepsy therapeutics. The knowledge and use of these principles can guide precision therapies in drug-refractory epilepsies.

    In their study on the reproductive health of women with epilepsy in India, Dr AN Sunil Kumar et al highlight increased menstrual problems and lesser knowledge of contraceptive methods in women with epilepsy as compared with healthy controls. This information is very important to raise awareness and seek remedial measures for these issues.

    Dr Siriporn Tiamkao et al from Thailand present the efficacy of generic intravenous levetiracetam in pediatric status epilepticus in their region with low side effects. Carol D'Souza et al from Mumbai, India explore the factors that help or hinder the prospects of employment in people with epilepsy and cite low seizure frequency and later onset of epilepsy as facilitating factors, whereas high job stress and cognitive and emotional difficulties as barriers for work. Further, we also present two interesting case vignettes on lithium toxicity and brivaracetam-induced behavioral changes to highlight the lesser-known adverse effects of medications.

    We hope to enthuse the readers with newer insights and research ideas in epilepsy, its impact, and related therapeutic advances. We appreciate the efforts of Dr Sanjib Sinha and his editorial team in shaping the previous issues and working toward the journal's progress. We also thank the untiring efforts of our reviewers who help us bring forth the scientific content to our readers. We would like to express our gratitude to Thieme Publications for their dedication and hard work in compiling this issue.

    We sincerely hope you will find this issue interesting and pertinent to your practice and research. Now, we also welcome submissions such as teaching EEGs, Neuroimage of the month (related to epilepsy), brief viewpoints on contemporary issues for people with epilepsy, and short communications. We are also reviving the Multiple-Choice Questions in Epilepsy, especially for our readers in training. Your valuable suggestions/inputs are solicited to enhance the outreach and impact of IJEP!


    #

    No conflict of interest has been declared by the author(s).

    Address for correspondence

    Man Mohan Mehndiratta, Principal Director
    Department of Neurology, Centre for Neurosciences, B.L. Kapur Hospital (Max Health Care Group)
    New Delhi 110005
    India   

    Publication History

    Article published online:
    26 June 2024

    © 2024. Indian Epilepsy Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

    Thieme Medical and Scientific Publishers Pvt. Ltd.
    A-12, 2nd Floor, Sector 2, Noida-201301 UP, India